Total Payments
$371,576
2024 Payments
$27,193
Companies
16
Transactions
309
Payment Breakdown by Category
Consulting$202,245 (54.4%)
Other$74,830 (20.1%)
Travel$64,116 (17.3%)
Research$23,270 (6.3%)
Food & Beverage$6,420 (1.7%)
Education$695.21 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $202,245 | 106 | 54.4% |
| Travel and Lodging | $64,116 | 91 | 17.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $48,721 | 15 | 13.1% |
| Honoraria | $26,109 | 9 | 7.0% |
| Unspecified | $23,270 | 15 | 6.3% |
| Food and Beverage | $6,420 | 71 | 1.7% |
| Education | $695.21 | 2 | 0.2% |
Payments by Type
General
$348,306
294 transactions
Research
$23,270
15 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $109,409 | 120 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $84,525 | 60 | $0 (2021) |
| PFIZER INC. | $59,303 | 42 | $0 (2024) |
| Seqirus USA Inc | $30,236 | 17 | $0 (2024) |
| AstraZeneca UK Limited | $18,522 | 14 | $0 (2022) |
| Dynavax Technologies Corporation | $14,325 | 12 | $0 (2024) |
| ModernaTX, Inc. | $12,614 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $12,157 | 8 | $0 (2024) |
| Saol Therapeutics Inc. | $7,218 | 5 | $0 (2021) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $5,288 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,193 | 20 | PFIZER INC. ($8,275) |
| 2023 | $53,408 | 42 | GlaxoSmithKline, LLC. ($16,285) |
| 2022 | $50,676 | 38 | AstraZeneca UK Limited ($18,522) |
| 2021 | $40,322 | 23 | Dynavax Technologies Corporation ($10,200) |
| 2020 | $39,212 | 16 | PFIZER INC. ($10,777) |
| 2019 | $32,944 | 61 | PFIZER INC. ($11,848) |
| 2018 | $26,752 | 18 | GlaxoSmithKline, LLC. ($21,101) |
| 2017 | $101,069 | 91 | Merck Sharp & Dohme Corporation ($61,584) |
All Payment Transactions
309 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| Category: Hepatitis B Vaccine | ||||||
| 11/04/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: VACCINES | ||||||
| 10/30/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 10/11/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 10/02/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Consulting Fee | Cash or cash equivalent | $875.00 | General |
| Category: Hepatitis B Vaccine | ||||||
| 07/30/2024 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| 07/24/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Consulting Fee | Cash or cash equivalent | $875.00 | General |
| Category: Hepatitis B Vaccine | ||||||
| 07/18/2024 | Seqirus USA Inc | — | Consulting Fee | Cash or cash equivalent | $5,877.70 | General |
| 06/11/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 05/15/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| 04/30/2024 | PFIZER INC. | ABRYSVO (Biological) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: VACCINES | ||||||
| 04/30/2024 | PFIZER INC. | ABRYSVO (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: VACCINES | ||||||
| 04/30/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: VACCINES | ||||||
| 04/13/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| 03/31/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 03/15/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| 03/12/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: VACCINES | ||||||
| 01/24/2024 | Seqirus USA Inc | — | Consulting Fee | Cash or cash equivalent | $1,154.00 | General |
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | FLUMIST QUADRIVALENT (Biological) | Consulting Fee | Cash or cash equivalent | $537.00 | General |
| Category: Respiratory | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | FLUMIST QUADRIVALENT (Biological) | Consulting Fee | Cash or cash equivalent | $1,074.00 | General |
| Category: Respiratory | ||||||
| 12/08/2023 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 10/11/2023 | AstraZeneca Pharmaceuticals LP | FLUMIST QUADRIVALENT (Biological) | Consulting Fee | Cash or cash equivalent | $2,013.75 | General |
| Category: Respiratory | ||||||
| 09/06/2023 | Seqirus USA Inc | FLUCELVAX QUADRIVALENT (Biological) | Consulting Fee | Cash or cash equivalent | $1,695.00 | General |
| Category: Vaccines | ||||||
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $589.80 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Food and Beverage | In-kind items and services | $517.85 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ZOSTER-006 | GlaxoSmithKline, LLC. | $5,173 | 1 |
| ZOSTER-006/022 QOL MS | GlaxoSmithKline, LLC. | $1,245 | 1 |
| ZOSTER 022 | GlaxoSmithKline, LLC. | $1,034 | 1 |
| A phase III, open label, multicenter study to evaluate the impact of reactogenicity on Quality of Life QoL , after intramuscular administration of GSK Biologicals candidate Herpes Zoster subunit HZ su vaccine GSK1437173A in adults 50 years of | GlaxoSmithKline, LLC. | $585.38 | 5 |
| ZOSTER-063 | GlaxoSmithKline, LLC. | $467.10 | 2 |
About Dr. Myron Levin, MD
Dr. Myron Levin, MD is a Pediatric Infectious Diseases healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306920038.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Myron Levin, MD has received a total of $371,576 in payments from pharmaceutical and medical device companies, with $27,193 received in 2024. These payments were reported across 309 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($202,245).
Ad
Practice Information
- Specialty Pediatric Infectious Diseases
- Location Aurora, CO
- Active Since 10/25/2006
- Last Updated 08/13/2012
- Taxonomy Code 2080P0208X
- Entity Type Individual
- NPI Number 1306920038
Products in Payments
- Heplisav-B (Drug) $14,325
- ZOSTAVAX (Biological) $10,566
- BEXSERO (Biological) $9,992
- PREVNAR 20 (Biological) $7,550
- SHINGRIX (Biological) $6,275
- FLUMIST QUADRIVALENT (Biological) $5,773
- VARIZIG (Drug) $5,593
- Synagis (Drug) $5,168
- FLUCELVAX QUADRIVALENT (Biological) $4,079
- FLUMIST (Drug) $2,625
- PREVNAR 13 (Biological) $2,450
- COMIRNATY (Biological) $2,100
- ABRYSVO (Biological) $2,025
- FLUMIST (Biological) $1,611
- EVUSHELD (Drug) $1,315
- NO PRODUCT DISCUSSED (Drug) $57.99
- SYNAGIS (Drug) $49.99
- Lioresal (baclofen) (Drug) $25.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Infectious Diseases Doctors in Aurora
Eric Simoes, Md, MD
Pediatric Infectious Diseases — Payments: $411,562
Pediatric Infectious Diseases $411,562
Dr. Edwin Asturias, Md, MD
Pediatric Infectious Diseases — Payments: $57,342
Pediatric Infectious Diseases $57,342
Mary Glode, Md, MD
Pediatric Infectious Diseases — Payments: $33,651
Pediatric Infectious Diseases $33,651
Samuel Dominguez, Md, MD
Pediatric Infectious Diseases — Payments: $17,554
Pediatric Infectious Diseases $17,554
Ann-Christine Nyquist, Md, MD
Pediatric Infectious Diseases — Payments: $12,719
Pediatric Infectious Diseases $12,719
Elizabeth Mcfarland, Md, MD
Pediatric Infectious Diseases — Payments: $3,549
Pediatric Infectious Diseases $3,549